Anavex Life Sciences Corp (AVXL)

[boi568]

Oh -- if we don't need to just count placebo-controlled results, then we get to count the 2-73 Phase 2a results and its extensions, which showed some intriguing outcomes for those with mild disease who were given higher doses (like SAVA did in their open label test).

Of course, no one has brought forward evidence that Anavex was playing games with its science underlying its trial, so you can still distinguish the trials if you wish.